Epidermal growth factor stimulates urokinase-type plasminogen activator expression in human gingival fibroblasts. Possible modulation by genistein and curcumin

Journal of Periodontal Research

Volumn 39, Issue 6, 2004, Pages 380-387

  Smith, Patricio C ^a   Santibañez, Juan F ^a   Morales, Juan P ^a   Martinez, Jorge ^a  

^a UNIVERSITY OF CHILE   (Chile)

Author keywords

c Jun N terminal kinase; Curcumin; Epidermal growth factor; Genistein; Gingival fibroblasts; Urokinase

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; CURCUMIN; GENISTEIN; MITOGEN ACTIVATED PROTEIN KINASE P38; PHYTOESTROGEN; PROTEIN C JUN; RECOMBINANT EPIDERMAL GROWTH FACTOR; UROKINASE;

ARTICLE; CELL ACTIVITY; CELL CULTURE; CELL STIMULATION; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG EFFECT; DRUG EXPOSURE; DRUG POTENCY; DRUG SPECIFICITY; ENZYME ACTIVITY; ENZYME REGULATION; EXTRACELLULAR MATRIX; FIBROBLAST; GINGIVA; HUMAN; HUMAN CELL; PERIODONTICS; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STATISTICAL SIGNIFICANCE;

CELLS, CULTURED; CURCUMIN; ENZYME ACTIVATION; EPIDERMAL GROWTH FACTOR; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FIBROBLASTS; GENE EXPRESSION; GENISTEIN; GINGIVA; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MAP KINASE SIGNALING SYSTEM; PHOSPHORYLATION; PHYTOESTROGENS; PLASMINOGEN ACTIVATORS; PROTEASE INHIBITORS; PROTEIN KINASE INHIBITORS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECOMBINANT PROTEINS; URINARY PLASMINOGEN ACTIVATOR;

EID: 8744252318     PISSN: 00223484     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0765.2004.00753.x     Document Type: Article

References (45)

1. Birkedal-Hansen H. Role of cytokines and inflammatory mediators in tissue destruction. J Periodont Res 1993;28:500-510.
2. Bartold PM, Walsh LJ, Narayanan S. Molecular and cell biology of the gingiva. Periodontol 2000 2000;24:28-55.
3. Xiao Y, Bunn CL, Bartold PM. Immunohistochemical demonstration of the plasminogen activator system in human gingival tissues and gingival fibroblasts. J Periodont Res 1998;33:17-26.
4. Kinnby B, Lindberg P, Lecander I, Matsson L. Localization of plasminogen activators and plasminogen inhibitors in human gingival tissues demonstrated by immunohistochemistry and in situ hybridization. Arch Oral Biol 1999;44:1027-1034.
5. Dano K, Andreasen PA, Grondhal-Hansen K, Kristensen P, Nielsen LS, Skriver L. Plasminogen activators, tissue degradation and cancer. Adv Cancer Res 1985;44:139-266.
6. Birkedal-Hansen H. Proteolytic remodeling of extracellular matrix. Curr Opin Cell Biol 1995;7:728-735.
7. Okada H, Murakami S. Cytokine expression in periodontal health and disease. Crit Rev Oral Biol Med 1998;9:248-266.
8. Tajima Y, Yokose S, Kahsimata M, Hiramatsu M, Minami N, Utsumi N. Epidermal growth factor expression in junctional epithelium of rat gingiva. J Periodont Res 1992;27:299-300.
9. Chang K-M, Lehrhaupt N, Lin LM, Feng H, Wu-Wang C-Y, Wang S-L. Epidermal growth factor in gingival crevicular fluid and its binding capacity in inflamed and non-inflamed human gingiva. Arch Oral Biol 1996;41:719-724.
10. Moulin V. Growth factors in skin wound healing. Eur J Cell Biol 1995;68:1-7.
11. Domeij H, Yucel-Lindberg T, Modéer T. Signal pathways involved in the production of MMP-1 and MMP-3 in human gingival fibroblasts. Eur J Oral Sci 2002;110:302-306.
12. Ravanti L, Hakkinen L, Larjava H et al. Transforming growth factor-beta induces collagenase-3 expression by human gingival fibroblasts via p38 mitogen-activated protein kinase. J Biol Chem 1999;274:37292-37300.
13. Aguirre Guiso JA, Alonso DF, Farias EF, Gomez DE, de Kier Joffè EB. Deregulation of the signaling pathways controlling urokinase production. Its relationship with the invasive phenotype. Eur J Biochem 1999;263:295-304.
14. Shin BA, Yoo HG, Kim HS et al. p38 MAPK pathway is involved in the urokinase plasminogen activator expression in human gastric SNU-638 cells. Oncol Rep 2003;10:1467-1471.
15. Miralles F, Parra M, Gaelles C, Nagamine Y, Felez J, Muñoz-Canoves P. UV irradiation induces the murine urokinase-type plasminogen activator gene via the c-Jun N-terminal kinase signaling pathway: requirement of an AP-1 enhancer element. Mol Cell Biol 1998;18:4537-4547.
16. Parra M, Lluis F, Miralles F, Gaelles C, Muñoz-Cánoves P. The c-Jun N-terminal kinase (JNK) signaling pathway mediates induction of urokinase-type plasminogen activator (uPA) by the alkylating agent MNNG. Blood 2000;96:1415-1424.
17. Witowsky J, Abell A, Johnson NL, Johnson GL, Cuevas BD. MEKK1 is required for inducible urokinase-type plasminogen activator expression. J Biol Chem 2003;278:5941-5946.
18. Santibañez JF, Navarro A, Martinez J. Genistein inhibits proliferation and in vitro invasive potential of human prostatic cancer cell lines. Anticancer Res 1997;17:1199-1204.
19. Duan W, Kuo C, Selvarajan S, Chua KY, Bay BH, Wong WSF. Antiinflammatory effects of genistein, a tyrosine kinase inhibitor, on a guinea pig model of asthma. Am J Respir Crit Care Med 2003; 167:185-192.
20. Surh YJ. Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer 2003;3:768-780.
21. Faúndez V, Krauss R, Holuigue L, Garrido J, Gonzalez A. Epidermal growth factor receptor in synaptic fractions of the rat central nervous system. J Biol Chem 1992;267:20363-20370.
22. Salazar G, Gonzalez A. Novel mechanism for regulation of epidermal growth factor receptor endocytosis revealed by protein kinase A inhibition. Mol Biol Cell 2002;13:1677-1693.
23. Larjava H, Heino J, Kähäri V-M, Vuorio E. Characterization of one phenotype of human periodontal granulation-tissue fibroblasts. J Dent Res 1989; 68:20-25.
24. Martinez J, Fuentes M, Cambiazo V, Santibañez JF. Bone extracellular matrix stimulates invasiveness of estrogen-responsive human mammary MCF-7 cells. Int J Cancer 1999;83:278-282.
25. Schlessinger J. Ligand-induced, receptor-mediated dimerization and activation of EGF receptor. Cell 2002;110:669-672.
26. Ulrich A, Schlessinger J. Signal transduction by receptors with tyrosine kinase activity. Cell 1990;61:203-212.
27. Vassalli JD, Sappino AP, Belin D. The plasminogen activator/plasmin system. J Clin Invest 1991;88:381-389.
28. Elliott SN, Wallace JL, McKnight W et al. Bacterial colonization and healing of gastric ulcers: the effects of epidermal growth factor. Am J Physiol Gastrointest Liver Physiol 2000;278:G105-G112.
29. Yang J, Tyler LW, Donoff RB et al. Salivary EGF regulates eosinophil-derived TNF-alpha expression in hamster oral wounds. Am J Physiol 1996;270:G191-G202.
30. Boyd D, Brattain M. Determination of the effects of epidermal growth factor on urokinase secretion and urokinase receptor display in well-differentiation human colon carcinoma cell line. Cancer Res 1989;49:1948-1953.
31. Boyd D. Examination of the effects of epidermal growth factor on the production of urokinase and the expression of the plasminogen activator receptor in a human colon cancer cell line. Cancer Res 1989;49:2427-2432.
32. Dubeau L, Jones PA, Rideout WM, Laug WE. Differential regulation of plasminogen activators by epidermal growth factor in normal and neoplastic human urothelium. Cancer Res 1988;48:5552-5556.
33. Besser D, Presta M, Nagamine Y. Elucidation of a signaling pathway induced by FGF-2 leading to uPA gene expression in NIH 3T3 fibroblasts. Cell Growth Differ 1995;6:1009-1017.
34. Shaulin E, Karim M. AP-1 as a regulator of cell life and death. Nat Cell Biol 2002;4:E131-E136.
35. Fanger GR, Johnson NL, Johnson GL. MEK kinases are regulated by EGF and selectively interact with Rac/Cdc42. EMBO J 1997;16:4961-4972.
36. Fanger GR, Widmann C, Porter AC, Sather S, Johnson GL, Vaillancourt RR. 14-3-3 proteins interact with specific MEK kinases. J Biol Chem 1998;273:3476-3483.
37. Lange-Carter GR, Johnson GL. Ras-dependent growth factor regulation of MEK kinase in PC12 cells. Science 1994;265:1458-1461.
38. Cuevas BD, Abell AN, Witowsky JA et al. MEKK1 regulates calpain-dependent proteolysis of focal adhesion proteins for rear-end detachment of migrating fibroblasts. EMBO J 2003;22:3346-3355.
39. Parkar MH, Kuru L, Giouzeli M, Olsen I. Expression of growth-factor receptors in normal and regenerating human periodontal cells. Arch Oral Biol 2001;46:275-284.
40. Albandar JM, Rams TE. Global epidemiology of periodontal diseases: an overview. Periodontol 2000 2002;29:7-10.
41. Huang MT, Smart RC, Wong CQ, Conney AH. Inhibitory effect of curcumin, chlorogenic acid, caffeic acid, and ferulic acid on tumor promotion in mouse skin by 12-O-tetradacanoyl phorbol13-acetate. Cancer Res 1988;48:5941-5946.
42. Abe Y, Hashimoto S, Horie T. Curcumin inhibition of inflammatory cytokine production by human peripheral blood monocytes and alveolar macrophages. Pharmacol Res 1999;39:41-47.
43. Barnes S. Effect of genistein on in vitro and in vivo models of cancer. J Nutr 1995;125:777s-783s.
44. Chen Y-R, Tan T-H. Inhibition of the c-Jun N-terminal kinase (JNK) signaling pathway by curcumin. Oncogene 1998;17:173-178.
45. Korutla L, Kumar M. Inhibitory effect of curcumin on epidermal growth factor receptor kinase activity in A431 cells. Biochim Biophys Acta 1994;1224:597-600.